Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,067 public trials 1,185 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, not recruiting

SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines

NCT04705389

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • Department of Dermatology, Medical University of Vienna Vienna, Austria
  • University Hospital of Helsinki, Finland Helsinki, Finland
  • Dermatology Dept, Hospital University of Tours Tours, France
  • Translational Skin Cancer Research Essen, Germany
View Trial Details
Active, not recruiting

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery

NCT06204159

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pennsylvania, Department of Radiology, Interventional Radiology Division Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Study of E7386 in Participants With Selected Advanced Neoplasms

NCT03264664

Conditions
Adenocarcinoma, Advanced Neoplasms, Carcinoma, +9 more
Locations
  • Mayo Clinic Comprehensive Caner Phoenix, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • California Liver Research Institute Pasadena, California, United States
  • Mayo Clinic Comprehensive Cancer Jacksonville, Florida, United States
View Trial Details
Active, not recruiting

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05789069

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax, Virginia, United States
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, Italy
View Trial Details
Active, not recruiting

CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

NCT04322955

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • The Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University Irving Medical Center New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Active, not recruiting

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

NCT01953588

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 860 locations
View Trial Details

Related conditions